Tenet Health(THC)

Search documents
Tenet Health(THC) - 2022 Q3 - Earnings Call Transcript
2022-10-21 17:16
Tenet Healthcare Corporation (NYSE:THC) Q3 2022 Earnings Conference Call October 21, 2022 10:00 AM ET Company Participants Will McDowell - Vice President, Investor Relations Saum Sutaria - Chief Executive Officer Dan Cancelmi - Executive Vice President and Chief Financial Officer Brett Brodnax - Chief Executive Officer, USPI Conference Call Participants John Ransom - Raymond James Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Whit Mayo - SVB Securities Pito Chickering - Deutsche Bank A.J. Rice - ...
Tenet Health(THC) - 2022 Q2 - Quarterly Report
2022-07-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2022 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-255 ...
Tenet Health(THC) - 2022 Q2 - Earnings Call Transcript
2022-07-22 20:20
Tenet Healthcare Corporation (NYSE:THC) Q2 2022 Earnings Conference Call July 22, 2022 10:00 AM ET Company Participants Will McDowell - IR Dan Cancelmi - EVP & Chief Financial Officer Ron Rittenmeyer - Executive Chairman Saum Sutaria - Chief Executive Officer Brett Brodnax - CEO of USPI Conference Call Participants A.J. Rice - Credit Suisse Whit Mayo - SVB Leerink Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Jason Cassorla - Citi Josh Raskin - Nephron Research Jamie Perse - Goldman Sachs Joh ...
Tenet Health(THC) - 2022 Q2 - Earnings Call Presentation
2022-07-22 13:23
Second Quarter 2022 Earnings Release Presentation July 21, 2022 Cautionary Statements 2 This presentation includes "forward-looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial position, operational and strategic initiatives, and developments in legislation, regulation, and the healthcare industry more generally. These forward-looking statements represent management's expectations, base ...
Tenet Health(THC) - 2022 Q1 - Quarterly Report
2022-04-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2022 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-25 ...
Tenet Health(THC) - 2022 Q1 - Earnings Call Transcript
2022-04-21 17:52
Tenet Healthcare Corporation (NYSE:THC) Q1 2022 Earnings Conference Call April 21, 2022 10:00 AM ET Company Participants Will McDowell - IR Dan Cancelmi - EVP & CFO Ron Rittenmeyer - Executive Chairman Saum Sutaria - CEO Conference Call Participants Josh Raskin - Nephron Research Justin Lake - Wolfe Research A.J. Rice - Credit Suisse Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Jason Cassorla - Citi Whit Mayo - SVB Leerink John Ransom - Raymond James Brian Ta ...
Tenet Health(THC) - 2021 Q4 - Annual Report
2022-02-17 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to (Registrant's telephone number, including area code) ________________________________________________________ Securities registered pursuant to Section 12( ...
Tenet Health(THC) - 2021 Q4 - Earnings Call Presentation
2022-02-14 10:30
| --- | --- | |-------|--------------------------------------| | | | | | Fourth Quarter 2021 Earnings Release | | | Presentation | | | February 7, 2022 | Cautionary Statements 2 This presentation includes "forward-looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial position, operational and strategic initiatives, and developments in legislation, regulation, and the healthcare industry ...
Tenet Health(THC) - 2021 Q4 - Earnings Call Transcript
2022-02-08 21:28
Tenet Healthcare Corporation (NYSE:THC) Q4 2021 Earnings Conference Call February 8, 2022 10:00 AM ET Company Participants Dan Cancelmi - EVP & CFO Ron Rittenmeyer - Executive Chairman Saum Sutaria - CEO Brett Brodnax - President & CEO, USPI Conference Call Participants Kevin Fischbeck - Bank of America Pito Chickering - Deutsche Bank Sarah James - Barclays Justin Lake - Wolfe Research Josh Raskin - Nephron Research A.J. Rice - Credit Suisse Jason Cassorla - Citi Brian Tanquilut - Jefferies Ben Hendrix - RB ...
Tenet Health(THC) - 2021 Q3 - Quarterly Report
2021-10-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2021 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) ________ ...